Financhill
Back

Onconetix Quote, Financials, Valuation and Earnings

Onconetix Price Quote

$0.36
+0.01 (+0%)
(Updated: December 21, 2024 at 5:40 AM ET)

Onconetix Key Stats

Sell
4
Onconetix (ONCO) is a Sell

Day range:
$0.35 - $0.38
52-week range:
$0.35 - $21.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.13
P/B ratio:
0.08%

Volume:
326.2K
Avg. volume:
240.4K
1-year change:
-95.44%
Market cap:
$2.9M
Revenue:
$58.5K
EPS:
$-99.52

How Much Does Onconetix Make?

Data Unavailable

Is Onconetix Growing As A Company?

Data Unavailable

Onconetix Stock Price Performance

  • Did Onconetix Stock Go Up Last Month?
    Onconetix share price went down by -67.88% last month
  • Did ONCO's Share Price Rise Over The Last Year?
    ONCO share price fell by -95.44% over the past 1 year

What Is Onconetix 52-Week High & Low?

  • What Is Onconetix’s 52-Week High Share Price?
    Onconetix has traded as high as $21.40 over the past 52 weeks
  • What Is Onconetix’s 52-Week Low Share Price?
    Onconetix has traded as low as $0.35 over the past 52 weeks

Onconetix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Onconetix?

Data Unavailable

Is Onconetix Cash Flow Positive?

Data Unavailable

Onconetix Return On Invested Capital

Data Unavailable

Onconetix Earnings Date & Stock Price

  • What Is Onconetix's Stock Price Today?
    A single share of ONCO can be purchased today for 0.35
  • What Is Onconetix’s Stock Symbol?
    Onconetix trades on the nasdaq under the ticker symbol: ONCO
  • When Is Onconetix’s Next Earnings Date?
    The next quarterly earnings date for Onconetix is scheduled on May 20, 2025
  • When Is ONCO's next ex-dividend date?
    Onconetix's next ex-dividend date is December 22, 2024
  • How To Buy Onconetix Stock?
    You can buy Onconetix shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Onconetix Competitors

  • Who Are Onconetix's Competitors?
    Below is a list of companies who compete with Onconetix or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Onconetix Dividend Yield

Data Unavailable

Onconetix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable